These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7101229)

  • 1. The stability of factor IX concentrate during storage.
    Suomela H; Vahtera E
    Thromb Haemost; 1982 Apr; 47(2):114-5. PubMed ID: 7101229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro stability studies of a Factor IX concentrate (Bebulin).
    Dal Bo Zanon R; Gazzetta R; Patrassi G; Stocco D; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):874-8. PubMed ID: 6200399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate.
    Goudemand J; Peynet J; Chambost H; Négrier C; Briquel ME; Claeyssens S; Derlon-Borel A; Guérois C; Caron C; Scherrmann JM; Debray M; Bridey F
    Thromb Haemost; 1998 Dec; 80(6):919-24. PubMed ID: 9869161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stability of two formulations of recombinant activated factor VIIa reconstituted in inappropriate solvents or at inappropriate volumes.
    Petersson B; Schönwandt AB; Thornstfeldt P; Nedergaard H; Jensen MB; Thornstergaard PB; Norsell T; Bjerre J
    Clin Ther; 2008 May; 30(5):917-23. PubMed ID: 18555938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
    J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of Beriplast P fibrin sealant: storage and reconstitution.
    Eberhard U; Broder M; Witzke G
    Int J Pharm; 2006 Apr; 313(1-2):1-4. PubMed ID: 16530994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin.
    Prowse CV; Boffa MC; Guthrie C; Pepper DS
    Thromb Haemost; 1980 Feb; 42(5):1368-77. PubMed ID: 7368144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditions.
    Rizzo F; Papasouliotis K; Crawford E; Dodkin S; Cue S
    Res Vet Sci; 2008 Aug; 85(1):166-70. PubMed ID: 17998140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and heat-treatment of factor-IX-concentrates.
    Stampe D; Wieland B; Köhle A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):523-7. PubMed ID: 2465966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the stability of lyophilized factor IX concentrate].
    Hoffmann S; Bykowska K; Lukasiak S; Lopaciuk S
    Acta Haematol Pol; 1985; 16(3-4):135-8. PubMed ID: 3835769
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y; Loyer F
    J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of serum TSH concentration after non refrigerated storage.
    Koliakos G; Gaitatzi M; Grammaticos P
    Panminerva Med; 1999 Jun; 41(2):99-101. PubMed ID: 10479905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.
    Refaai MA; Van Cott EM; Lukoszyk M; Hughes J; Eby CS
    Lab Hematol; 2006; 12(2):99-102. PubMed ID: 16751138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of six activated partial thromboplastin time reagents: intrinsic system factors' sensitivity and responsiveness.
    Hales SC; Johnson GS; Wagner D
    Clin Lab Sci; 1990; 3(3):194-6. PubMed ID: 10149038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The manufacturing process for recombinant factor IX.
    Harrison S; Adamson S; Bonam D; Brodeur S; Charlebois T; Clancy B; Costigan R; Drapeau D; Hamilton M; Hanley K; Kelley B; Knight A; Leonard M; McCarthy M; Oakes P; Sterl K; Switzer M; Walsh R; Foster W
    Semin Hematol; 1998 Apr; 35(2 Suppl 2):4-10. PubMed ID: 9565160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.